March 21, 2024
The Third Circuit on Thursday upheld a Pennsylvania federal judge's ruling that a putative class of investors alleging biopharmaceutical company Ocugen Inc. made misleading statements about its ability to quickly produce a COVID-19 vaccine failed to state a claim against the company.
March 03, 2023
Citing inadequate claims, a Pennsylvania federal judge on Friday tossed a proposed class action against biopharmaceutical company Ocugen Inc. filed by investors claiming the company made misleading statements regarding a COVID-19 vaccine.
September 01, 2021
Pomerantz LLP, Levi & Korsinsky LLP and Johnson Fistel LLP are vying for lead counsel status in a proposed securities class action against biopharmaceutical company Ocugen Inc. over allegedly misleading statements regarding a COVID-19 vaccine.